Secukinumab retention and safety in patients with active psoriatic arthritis or ankylosing spondylitis: 2 year interim results of the observational SERENA study
Gullick, Nicola
Gullick, Nicola
Citations
Altmetric:
Affiliation
10. Gaffney K, Kiltz U, Sfikakis P, Gullick N
Other Contributors
Publication date
2022
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Not available
Citation
10. Gaffney K, Kiltz U, Sfikakis P, Gullick N, et al. Secukinumab retention and safety in patients with active psoriatic arthritis or ankylosing spondylitis: 2 year interim results of the observational SERENA study. Rheumatology 61(s1) April 2022
Type
Article